RSV
Who is at risk?
While RSV can affect all age groups, it is particularly dangerous for:
- Infants and young children under 2 years of age,
- Older adults,
- People with weakened immune systems,
- People with chronic lung conditions.
How can I protect myself?
For infants and young children
To protect the youngest ones from RSV, it is recommended to avoid contact with individuals showing symptoms of respiratory infections. Additionally, there is a new passive immunization for infants using the monoclonal antibody Nirsevimab (Beyfortus®). This immunization is recommended for all infants at the start of their first RSV season. Ideally, the immunization should be administered in autumn (October) or, for winter births, as early as possible. The costs are covered by mandatory health insurance.
For adults aged 60 and older
Since this year, two RSV vaccines - Arexvy® and Abrysvo® - have been approved in Switzerland for adults aged 60 and older. The latter is also approved for pregnant women from the 32nd week of pregnancy to protect newborns. However, insurance coverage for these vaccines has not yet been clarified.
Vaccinating close contacts alone is not sufficient to adequately protect infants, so antibody immunization is strongly recommended to shield them during their first RSV season. The Travel Clinic UZH does not offer RSV immunizations for infants. However, for adults in risk groups who wish to be vaccinated against RSV with the Arexvy® vaccine, this service is available (currently at their own expense) at the Travel Clinic UZH.
Price:
217.60 CHF per dose
plus consultation and injection fee